פאנדי 50 יח'מל ( פקטור 8 )
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
FACTOR VIII (HUMAN)
Available from:
MEDICI MEDICAL LTD, ISRAEL
ATC code:
B02BD02
Pharmaceutical form:
אבקה להכנת תמיסה לזריקה
Composition:
FACTOR VIII (HUMAN) 500 IU
Administration route:
תוך-ורידי
Prescription type:
מרשם נדרש
Manufactured by:
INSTITUTO GRIFOLS S.A.,SPAIN,BARCELONA
Therapeutic group:
COAGULATION FACTOR VIII
Therapeutic area:
COAGULATION FACTOR VIII
Therapeutic indications:
Is indicated for the prevention and control of bleeding in patients with moderate or severe factor VIII deficiency due to classical hemophilia A . Fanhdi is not effective in controlling the bleeding of patients with Von Willebrond's disease.
Authorization date:
2020-12-31
